| A conformational immunogen on VP-2 of infectious bursal disease virus that induces virus-neutralizing antibodies that passively protect chickens KJ Fahey, K Erny, J Crooks Journal of General Virology 70 (6), 1473-1481, 1989 | 316 | 1989 |
| The effect of nurse-led diabetes self-management education on glycosylated hemoglobin and cardiovascular risk factors: a meta-analysis JKT Tshiananga, S Kocher, C Weber, K Erny-Albrecht, K Berndt, K Neeser The Diabetes Educator 38 (1), 108-123, 2012 | 259 | 2012 |
| ESX: a structurally unique Ets overexpressed early during human breast tumorigenesis CH Chang, GK Scott, WL Kuo, X Xiong, Y Suzdaltseva, JW Park, P Sayre, ... Oncogene 14 (13), 1617-1622, 1997 | 226 | 1997 |
| Virus-neutralizing and passively protective monoclonal antibodies to infectious bursal disease virus of chickens KJ Fahey, P McWaters, MA Brown, K Erny, VJ Murphy, DR Hewish Avian Diseases, 365-373, 1991 | 127 | 1991 |
| Molecular characterization of highly virulent fowl adenoviruses associated with outbreaks of inclusion body hepatitis KM Erny, DA Barr, KJ Fahey Avian Pathology 20 (4), 597-606, 1991 | 103 | 1991 |
| Ets regulation of the erbB2 promoter GK Scott, CH Chang, KM Erny, F Xu, WJ Fredericks, FJ Rauscher, ... Oncogene 19 (55), 6490-6502, 2000 | 101 | 2000 |
| Involvement of the Tpl-2/cot oncogene in MMTV tumorigenesis. KM Erny, J Peli, JF Lambert, V Muller, H Diggelmann Oncogene 13 (9), 2015-2020, 1996 | 91 | 1996 |
| Expression in Escherichia coli of cDNA fragments encoding the gene for the host-protective antigen of infectious bursal disease virus AA Azad, KJ Fahey, SA Barrett, KM Erny, PJ Hudson Virology 149 (2), 190-198, 1986 | 79 | 1986 |
| Cost-effectiveness of basal insulin from a US health system perspective: comparative analyses of detemir, glargine, and NPH WJ Valentine, AJ Palmer, KM Erny-Albrecht, JA Ray, D Cobden, V Foos, ... Advances in therapy 23, 191-207, 2006 | 65 | 2006 |
| Immunological and molecular comparison of fowl adenovirus serotypes 4 and 10 K Erny, J Pallister, M Sheppard Archives of Virology 140, 491-501, 1995 | 57 | 1995 |
| Exenatide versus insulin glargine: a cost-effectiveness evaluation in patients with Type 2 diabetes in Switzerland. M Brändle, KM Erny-Albrecht, G Goodall, GA Spinas, P Streit, ... International journal of clinical pharmacology and therapeutics 47 (8), 501-515, 2009 | 42 | 2009 |
| Evaluating the cost-effectiveness of therapy conversion to insulin detemir in patients with type 2 diabetes in Germany: a modelling study of long-term clinical and cost outcomes WJ Valentine, G Goodall, M Aagren, S Nielsen, AJ Palmer, ... Advances in therapy 25, 567-584, 2008 | 40 | 2008 |
| Therapy conversion to insulin detemir among patients with type 2 diabetes treated with oral agents: a modeling study of cost-effectiveness in the United States WJ Valentine, KM Erny-Albrecht, JA Ray, S Roze, D Cobden, AJ Palmer Advances in therapy 24, 273-290, 2007 | 39 | 2007 |
| Long-acting insulin analogs: a review of “real-world” effectiveness in patients with type 2 diabetes R F Pollock, K M Erny-Albrecht, A Kalsekar, D Bruhn, W J Valentine Current diabetes reviews 7 (1), 61-74, 2011 | 35 | 2011 |
| Cost-effectiveness of pioglitazone in type 2 diabetes patients with a history of macrovascular disease: a German perspective WA Scherbaum, G Goodall, KM Erny-Albrecht, M Massi-Benedetti, ... Cost Effectiveness and Resource Allocation 7, 1-12, 2009 | 29 | 2009 |
| Cost-effectiveness of pioglitazone in patients with type 2 diabetes and a history of macrovascular disease in a Swiss setting KM Erny-Albrecht, E Erdmann Swiss Medical Weekly 139 (1112), 173-173, 2009 | 22 | 2009 |
| A Vβ4‐specific superantigen encoded by a new exogenous mouse mammary tumor virus I Maillard, K Erny, H Acha‐Orbea, H Diggelmann European journal of immunology 26 (5), 1000-1006, 1996 | 22 | 1996 |
| Cost-effectiveness of self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin: response to Davidson K Neeser, KM Erny-Albrecht, C Weber Diabetes Care 29 (2), 480-480, 2006 | 18 | 2006 |
| Corporatisation of general practice–impact and implications K Erny-Albrecht, P Bywood PHCRIS Policy Issue Review, 1-53, 2016 | 17 | 2016 |
| Predictive risk models to identify people with chronic conditions at risk of hospitalisation J Oliver-Baxter, P Bywood, K Erny-Albrecht Adelaide: PHCRIS Policy Issue Review, 2015 | 11 | 2015 |
